Logan Capital Management Inc. decreased its holdings in Genpact Limited (NYSE:G - Free Report) by 26.5% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 19,354 shares of the business services provider's stock after selling 6,990 shares during the quarter. Logan Capital Management Inc.'s holdings in Genpact were worth $831,000 at the end of the most recent quarter.
Several other hedge funds also recently modified their holdings of the stock. Atlas Capital Advisors Inc. grew its position in Genpact by 55.8% during the fourth quarter. Atlas Capital Advisors Inc. now owns 603 shares of the business services provider's stock valued at $26,000 after buying an additional 216 shares during the period. Stifel Financial Corp lifted its holdings in shares of Genpact by 1.0% in the fourth quarter. Stifel Financial Corp now owns 30,821 shares of the business services provider's stock worth $1,324,000 after buying an additional 291 shares in the last quarter. CIBC Asset Management Inc boosted its holdings in Genpact by 5.5% in the 4th quarter. CIBC Asset Management Inc now owns 5,692 shares of the business services provider's stock valued at $244,000 after purchasing an additional 297 shares during the period. Tealwood Asset Management Inc. grew its position in Genpact by 1.4% during the fourth quarter. Tealwood Asset Management Inc. now owns 24,658 shares of the business services provider's stock worth $1,059,000 after buying an additional 339 shares in the last quarter. Finally, UMB Bank n.a. lifted its position in Genpact by 55.7% during the fourth quarter. UMB Bank n.a. now owns 1,210 shares of the business services provider's stock valued at $52,000 after purchasing an additional 433 shares during the last quarter. Hedge funds and other institutional investors own 96.03% of the company's stock.
Insider Activity
In other Genpact news, CEO Balkrishan Kalra sold 13,600 shares of the business's stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $48.89, for a total value of $664,904.00. Following the completion of the transaction, the chief executive officer now directly owns 310,246 shares in the company, valued at approximately $15,167,926.94. The trade was a 4.20% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Nicholas C. Gangestad purchased 2,000 shares of the company's stock in a transaction dated Tuesday, May 13th. The shares were acquired at an average price of $43.97 per share, for a total transaction of $87,940.00. Following the purchase, the director now directly owns 2,000 shares of the company's stock, valued at approximately $87,940. The trade was a ∞ increase in their position. The disclosure for this purchase can be found here. Insiders own 3.07% of the company's stock.
Genpact Price Performance
Genpact stock traded up $0.41 during mid-day trading on Friday, hitting $44.28. The stock had a trading volume of 2,286,869 shares, compared to its average volume of 1,369,755. The company has a current ratio of 2.16, a quick ratio of 1.85 and a debt-to-equity ratio of 0.50. The firm's 50 day moving average is $48.13 and its 200 day moving average is $47.09. The firm has a market capitalization of $7.78 billion, a P/E ratio of 15.59, a P/E/G ratio of 1.84 and a beta of 1.02. Genpact Limited has a one year low of $30.38 and a one year high of $56.76.
Genpact (NYSE:G - Get Free Report) last issued its quarterly earnings data on Wednesday, May 7th. The business services provider reported $0.84 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.80 by $0.04. The business had revenue of $1.21 billion for the quarter, compared to analysts' expectations of $1.21 billion. Genpact had a return on equity of 22.50% and a net margin of 10.77%. The company's revenue for the quarter was up 7.4% on a year-over-year basis. During the same period in the prior year, the firm earned $0.73 EPS. On average, sell-side analysts forecast that Genpact Limited will post 3.21 earnings per share for the current fiscal year.
Analyst Upgrades and Downgrades
G has been the topic of several research reports. Robert W. Baird decreased their price target on shares of Genpact from $56.00 to $50.00 and set a "neutral" rating on the stock in a research note on Thursday, May 8th. TD Cowen raised shares of Genpact from a "hold" rating to a "buy" rating and raised their target price for the company from $45.00 to $60.00 in a research note on Friday, February 7th. Mizuho lifted their target price on Genpact from $45.00 to $55.00 and gave the stock a "neutral" rating in a report on Monday, February 10th. Needham & Company LLC cut their price target on Genpact from $55.00 to $50.00 and set a "buy" rating for the company in a report on Thursday, May 8th. Finally, Jefferies Financial Group raised Genpact from a "hold" rating to a "buy" rating and raised their price objective for the stock from $44.00 to $55.00 in a research note on Tuesday, January 21st. Four analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus target price of $50.71.
Get Our Latest Stock Analysis on Genpact
Genpact Profile
(
Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Further Reading

Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.